Hydrus Microstent for Glaucoma

An advanced MIGS Implant for Glaucoma using a tiny canal-based microstent designed to enhance natural fluid outflow, reduce intraocular pressure, and support long-term glaucoma control.

FDA Approved

Advanced Technology

At a Glance

The Hydrus Microstent is a minimally invasive glaucoma surgery (MIGS) implant that helps lower intraocular pressure by improving fluid drainage through Schlemm’s canal, the eye’s natural outflow pathway.

Hydrus Microstent implantation

Transparent pricing with full aftercare support

Specialist glaucoma and cataract surgeons with advanced diagnostics

London, Surrey, Sussex

Key Benefits

What is the Hydrus™ Microstent?

The Hydrus Microstent is a tiny, flexible implant, roughly the size of an eyelash, designed to improve the eye’s natural fluid outflow and lower intraocular pressure (IOP), a key factor in glaucoma management.

 

The device is made from nitinol, a biocompatible metal alloy also used in other medical implants. It is inserted into Schlemm’s canal, where it acts as both a bypass across the trabecular meshwork (the usual site of fluid resistance) and a scaffold that gently widens the drainage channel.

 

Hydrus is usually implanted at the time of cataract surgery but can also be used as a stand-alone procedure, helping increase fluid outflow and reduce pressure without creating large incisions or altering conjunctival tissue.

Types of MIGS Performed at Centre for Sight

1

A microscopic implant placed into the eye’s natural drainage channel (Schlemm’s canal) to improve fluid outflow and lower eye pressure. Commonly performed alongside cataract surgery in patients with mild to moderate open-angle glaucoma.

2

A flexible, scaffold-like implant inserted into Schlemm’s canal that both bypasses resistance and gently dilates the natural drainage pathway. Hydrus is designed to provide more extensive coverage of the canal than a single stent and is often chosen for patients who require greater pressure reduction at the time of cataract surgery.

3

A laser-based MIGS procedure that creates precise micro-channels in the trabecular meshwork to enhance aqueous outflow. ELIOS requires no implants and preserves the eye’s natural anatomy, making it an attractive option for patients undergoing cataract surgery.

4

While not implant-based MIGS, selective laser trabeculoplasty (SLT) and direct SLT (DSLT) are often used alongside or prior to MIGS to reduce eye pressure non-invasively by improving trabecular meshwork function.

Comparing MIGS and Glaucoma Treatment Options

Please note that your consultant will recommend the most suitable treatment option tailored to your eye health, vision goals and lifestyle.

Procedure
Type

How it works

Best For

Pros

Cons

Procedure
Type

iStent/iStent Inject

How it works

Micro-bypass stent improves trabecular outflow via Schlemm’s canal

Best For

Mild–moderate open-angle glaucoma with cataract

Pros

Proven safety profile; reduces drop burden; quick recovery

Cons

Pressure reduction may be modest in some patients

Procedure
Type

Hydrus Microstent

How it works

Scaffold dilates and supports Schlemm’s canal while bypassing resistance

Best For

Mild–moderate glaucoma needing greater pressure reduction

Pros

Broader canal coverage; effective IOP lowering

Cons

Implant-based; usually combined with cataract surgery

Procedure
Type

SLT

How it works

Laser stimulates trabecular meshwork to improve drainage

Best For

Early glaucoma or ocular hypertension

Pros

Non-invasive; repeatable; no implants

Cons

Effect may diminish over time

Procedure
Type

DSLT

How it works

Automated, non-contact laser treatment

Best For

Early or first-line glaucoma treatment

Pros

Comfortable; quick; no contact lens

Cons

Not suitable for all eye anatomies

What Are the Benefits and Risks of Hydrus?

Your surgeon will speak with you about the benefits and risks involved before your procedure.

Frame 35 2

Benefits of Hydrus Microstent:

Improved eye pressure control

helping reduce glaucoma progression risk

Reduced reliance on eye drops

for many patients, long-term studies show a significant proportion

Minimally invasive

small incisions and shorter recovery than traditional glaucoma surgery

Established safety profile

with long-term clinical follow-up

Frame 35 3

Risks/side effects (not exhaustive):

Mild bleeding or transient irritation after surgery

Temporary blurry vision or eye redness as the eye heals

Rarely, stent blockage or displacement may require adjustment

Some patients may still require glaucoma drops or further treatment

Not Sure If You're Eligible?

Book a comprehensive eye examination to better understand your vision and available treatment options.

Who Is Suitable for Hydrus?

Your surgeon will speak with you about your suitability prior to carrying out the procedure

Frame 35 4

Hydrus is typically offered to patients who:

Have mild to moderate open-angle glaucoma

Are taking pressure-lowering eye drops but seek greater control

Are undergoing or have significant cataract-related vision impairment

Are looking to reduce medication burden

Frame 35 5

Suitability is confirmed after a thorough glaucoma assessment, including pressure measurement, optic nerve evaluation, and imaging of the drainage angle.

 

Hydrus is not usually recommended for angle closure, neovascular, or secondary glaucomas where the drainage anatomy is significantly altered.

Costs and Finance Options

Centre for Sight offers transparent pricing for Hydrus including consultant-led surgery, laser-assisted precision, anaesthetic care, and comprehensive aftercare. Consultation: from £445 (This covers specialist assessment and advanced diagnostics and is required before treatment.)

SLT and DSLT

Bespoke Price

Per Eye

Consultant-led glaucoma laser treatment

Clinically proven pressure-lowering laser

Outpatient, non-invasive procedure

May reduce or replace glaucoma eye drops

24-hour emergency support

Post-treatment monitoring and follow-up included

Hydrus

Bespoke Price

Per Eye

Consultant-led glaucoma treatment

Hydrus Microstent implantation

Often performed with cataract surgery

Advanced diagnostics and surgical planning

24-hour support and structured aftercare

iStent

Bespoke Price

Per Eye

Consultant-led glaucoma surgery​

iStent / iStent inject implant​

Advanced diagnostics and surgical planning

Often performed with cataract surgery

24-hour emergency support

Structured one-year follow-up

Flexible Financing Options

Private Medical Insurance​

Many of our Consultants work with all the major insurance providers*

Self Pay

Pay in full for patients who prefer a straightforward approach

0% APR Financing

6-24 month payment plans with approved credit

Military Discount

5% discount for active military and veterans

*Private Medical Insurance is unlikely to cover Laser Eye Surgery Procedures, Implantable Contact Lenses, or Laser Lens Replacement

FAQs

Below are answers to some of the most frequently asked questions about the Hydrus Microstent, to help you understand whether it may be right for you.

It’s a tiny implant placed in the eye to improve natural fluid outflow and lower pressure in glaucoma.

Hydrus has a well-studied safety profile, with long-term clinical data showing positive outcomes with low serious complication rates.

Over 2000 procedures have been performed as part of clinical studies or global registries.

In addition to the HYDRUS II and HYDRUS IV trials, the Hydrus technology is also being studied internationally in both cataract and stand-alone glaucoma surgery settings in various types and severities of glaucoma.

According to the study presented at the XXIX Congress of the ESCRS, it is effective at lowering intraocular pressure and reduces the need for medications in patients with primary open angle glaucoma (POAG).

Many patients reduce or stop glaucoma medications, though some may still need them depending on pressure targets.

No — Hydrus helps control pressure and slow progression but does not reverse existing optic nerve damage.

It’s performed under anaesthesia; most patients experience minimal discomfort.

An option to enhance aqueous outflow and reduce pressure further can be achieved by opening the 3 windows on the Hydrus by using a Nd: YAG laser.

Early European studies (on file with Ivantis, Inc.) have shown a dramatic reduction of eye pressure.

Have Questions?

Our patient care team is here to answer any questions you may have.

Patient Success Stories

Videos

Procedure Video

Procedure Video

About Centre for Sight

Certifications & Recognition

The Power List 2026

Global Top 50: Mr. Sheraz Daya

Top 1% Surgeons

National recognition

CQC Accredited

Highest safety standards

5-Star Rated

Patient satisfaction